GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
110 hedge funds and large institutions have $214M invested in GenMark Diagnostics, Inc in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
-1
Holders Change %
-0.9%
% of All Funds
2.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
30
Reduced
36
Closed
24
Calls
$682K
Puts
$917K
Net Calls
-$235K
Net Calls Change
-$235K
Top Buyers
| 1 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$3.68M |
| 2 |
Millennium Management
New York
|
+$3.12M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$2.86M |
| 4 |
NIM
Needham Investment Management
New York
|
+$2.67M |
| 5 |
EP
Eversept Partners
New York
|
+$2.16M |
Top Sellers
| 1 |
CCM
Cadian Capital Management
New York
|
-$8.36M |
| 2 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
-$4.7M |
| 3 |
JPMorgan Chase & Co
New York
|
-$3.59M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.89M |
| 5 |
Morgan Stanley
New York
|
-$2.32M |